The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.

The vast majority of breast cancers are carcinomas that arise from mammary epithelial cells (MECs). One of the key early events in tumorigenic transformation is the ability of cells to overcome replicative senescence. However, the precise genetic changes that are responsible for this event in MECs is largely unknown. Here, we report that Bmi-1, originally identified as a c-Myc cooperating oncoprotein, can bypass senescence, extend the replicative life span, and immortalize MECs. Furthermore, Bmi-1 was overexpressed in immortal MECs and several breast cancer cell lines. Overexpression of Bmi-1 in MECs led to activation of human telomerase reverse transcriptase (hTERT) transcription and induction of telomerase activity. Telomerase induction by Bmi-1 was an early event in the extension of the replicative life span and immortalization. Bmi-1 was not overexpressed in hTERT-immortalized MECs, suggesting that Bmi-1 functions upstream of hTERT. Although, c-Myc has been reported to induce telomerase in MECs, Bmi-1 appeared to act independently of c-Myc binding sequences in the hTERT promoter. Deletion analysis of the Bmi-1 protein suggested that the RING finger, as well as a conserved helix-turn-helix-turn domain, were required for its ability to induce telomerase and immortalize MECs. These data suggest that Bmi-1 regulates telomerase expression in MECs and plays a role in the development of human breast cancer.

[1]  Thea D. Tlsty,et al.  Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.

[2]  G. Demers,et al.  Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes. , 1994, Cold Spring Harbor symposia on quantitative biology.

[3]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[4]  M. Sofroniew,et al.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.

[5]  Anton Berns,et al.  Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.

[6]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[7]  Xiao Zhen Zhou,et al.  The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor , 2001, Cell.

[8]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[9]  J. Cleveland,et al.  The Max Network Gone Mad , 2001, Molecular and Cellular Biology.

[10]  J. McDougall,et al.  Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.

[11]  Goberdhan P Dimri,et al.  Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor , 2000, Molecular and Cellular Biology.

[12]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[13]  Nikita Popov,et al.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[15]  Young-Hwa Song,et al.  Identification of Mad as a repressor of the human telomerase (hTERT) gene , 2000, Oncogene.

[16]  E. Campo,et al.  BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. , 2001, Cancer research.

[17]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  O. Pereira-smith,et al.  Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.

[19]  Mark J Alkema,et al.  Perturbation of B and T cell development and predisposition to lymphomagenesis in EμBmi1 transgenic mice require the Bmi1 RING finger , 1997, Oncogene.

[20]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[21]  D. Wazer,et al.  Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. , 1994, Molecular and cellular biology.

[22]  D. Wazer,et al.  Human Papillomavirus Type 16 E6-Induced Degradation of E6TP1 Correlates with Its Ability To Immortalize Human Mammary Epithelial Cells , 2001, Journal of Virology.

[23]  P. Yaswen,et al.  Growth, differentiation, and transformation of human mammary epithelial cells in culture. , 1994, Cancer treatment and research.

[24]  Goberdhan P Dimri,et al.  Molecular and cell biology of replicative senescence. , 1994, Cold Spring Harbor symposia on quantitative biology.

[25]  Mark J Alkema,et al.  Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. , 1997, Genes & development.

[26]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[27]  Brian J. Reid,et al.  Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest , 1999, Molecular and Cellular Biology.

[28]  T. Lange,et al.  Tankyrase promotes telomere elongation in human cells , 2000, Current Biology.

[29]  V. Band,et al.  Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells , 1991, Journal of virology.

[30]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Wazer,et al.  Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. , 1997, Cancer Research.

[32]  C. Meijer,et al.  Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. , 2001, Blood.

[33]  W. Hahn,et al.  Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics , 2000, Molecular and Cellular Biology.

[34]  R. Reddel.  Genes Involved in the Control of Cellular Proliferative Potential a , 1998, Annals of the New York Academy of Sciences.

[35]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[36]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[37]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[38]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[39]  A. Otte,et al.  Polycomb group protein complexes: do different complexes regulate distinct target genes? , 1999, Biochimica et biophysica acta.

[40]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[42]  D. Wazer,et al.  Mutant p53-induced immortalization of primary human mammary epithelial cells. , 1996, Cancer research.

[43]  Heidi S. Liss,et al.  Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase* , 2000, The Journal of Biological Chemistry.

[44]  C. Englert,et al.  Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. , 2000, Cancer research.

[45]  V. Dulic,et al.  Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts , 1999, Molecular and Cellular Biology.

[46]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[47]  D. Wazer,et al.  Multiple Genetic Changes Are Required for Efficient Immortalization of Different Subtypes of Normal Human Mammary Epithelial Cells , 2001, Radiation research.

[48]  J. R. Smith,et al.  Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein , 1996, Molecular and cellular biology.

[49]  J. Campisi,et al.  TIN2, a new regulator of telomere length in human cells , 1999, Nature Genetics.

[50]  J. Shay,et al.  Cellular senescence as a tumor-protection mechanism: the essential role of counting. , 2001, Current opinion in genetics & development.

[51]  V. Pirrotta,et al.  Polycombing the Genome: PcG, trxG, and Chromatin Silencing , 1998, Cell.

[52]  J. Campisi.  Replicative Senescence: An Old Lives' Tale? , 1996, Cell.

[53]  W. Alexander,et al.  Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice , 1991, Cell.

[54]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[55]  D. Liao,et al.  c-Myc in breast cancer. , 2000, Endocrine-related cancer.

[56]  J W Gray,et al.  The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. , 2001, Cancer research.

[57]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[58]  V. Lundblad,et al.  The telomerase reverse transcriptase: components and regulation. , 1998, Genes & development.

[59]  M. Lohuizen,et al.  The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression , 2001, British Journal of Cancer.

[60]  C. Greider,et al.  Telomerase activation: one step on the road to cancer? , 1999 .

[61]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[62]  F. Zindy,et al.  c-Myc-mediated Regulation of Telomerase Activity Is Disabled in Immortalized Cells* , 2001, The Journal of Biological Chemistry.

[63]  D. Wazer,et al.  Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[64]  V. Band.  The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization. , 1998, International journal of oncology.

[65]  B. van Steensel,et al.  Control of Human Telomere Length by TRF1 and TRF2 , 2000, Molecular and Cellular Biology.

[66]  F. Ishikawa,et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas , 1998, Nature Genetics.

[67]  J. Shay,et al.  Telomerase and cancer. , 2001, Human molecular genetics.

[68]  D. Beach,et al.  p16INK4A and p19ARF act in overlapping pathways in cellular immortalization , 2000, Nature Cell Biology.

[69]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[71]  C. Dang,et al.  Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity , 1996, Molecular and cellular biology.